The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

On December 20, 2024, pharmaceutical company Eli Lilly announced that the FDA approved its first and only obstructive sleep ...

WAKE-UP CALL: 104m Indians or 11% of the population suffer from obstructive sleep apnea, according to a 2023 AIIMS study ...

Check out all our end-of-year content—the latest Heart Sounds podcast reviews the reporters’ own favorite stories for 2024, ...

Given Wegovy’s success and record-high sales, a wave of investments has gone into the obesity space over the last couple of ...

Eli Lilly’s Zepbound drug holds potential to dominate the global obesity market due to its superior efficacy and strategic ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 483.76% and ...

Lenacapavir for Alzheimer’s, an orca attacking a shark, and a moon landing are set to mark key scientific and technological ...

It hasn’t been a smooth year for the two pharma giants, but events in the fourth quarter widened the gap between them.

New research suggests that 15 million Americans have an elevated risk of heart failure. Here's what may put you at risk, and ...

After about 10 months of being on Ozempic and working my way up to a 1-mg dose, I lost 40 pounds effortlessly. Sugar cravings ...

The Houthis, an Iranian-backed group based in Yemen, have launched repeated attacks despite the Israeli military’s retaliatory airstrikes. By Adam Rasgon Stepped up attacks by Russia are ...